01Approach to the Critical Patient/attcp39

Time critical priorities

›Cauda equina syndrome emergency priorities

›Spinal surgery consultation now for suspected cauda equina syndrome

›Transfer to surgical capable center if no on site decompression capacity

›Operating room readiness trigger with progressive neurologic deficit

›Urgent MRI lumbosacral spine without delay

›MRI target within hours when red flags present

›CT myelography pathway if MRI contraindicated or unavailable

›Bladder dysfunction pathway

›Bladder scan post void residual

›If urinary retention, urethral catheter for decompression and output monitoring

›Neuro protection and monitoring

›Frequent lower extremity motor and sensory reassessment

›Escalate if new bilateral weakness or expanding saddle anesthesia

›Time to decompression principle

›Best neurologic and bladder outcomes with early surgical decompression

›Class I recommendation based on expert consensus for urgent decompression once confirmed

Key concepts

›Core concepts

›Cauda equina syndrome definition

›Lumbosacral nerve root dysfunction from spinal canal compression

›Typical injury level below conus medullaris

›Hallmark clinical triad concept

›Bilateral radicular pain or neurologic deficit

›Saddle anesthesia or perineal sensory change

›Bladder or bowel dysfunction

›High risk etiologies

›Large central lumbar disc herniation

02History/hx44

Presentation pattern

›Symptom pattern

›Back pain and radicular symptoms

›Severe low back pain

›Bilateral sciatica

›Sensory symptoms

›Saddle anesthesia

›Perineal numbness or tingling

›Bladder symptoms

›Urinary retention

›Overflow incontinence

›Bowel and sexual symptoms

›Fecal incontinence

›Constipation with reduced rectal sensation

›Sexual dysfunction

Red flag timeline and triggers

›Timing and progression

›Onset and trajectory

›Sudden onset after lifting or strain

›Progressive deficits over hours to days

›Preceding spinal symptoms

›Known lumbar disc disease

›Recent worsening radicular pain

›Procedural and trauma triggers

›Recent spinal surgery or epidural procedure

›Recent trauma with back pain

›Systemic triggers

›Fever or chills

03Physical Exam/exam33

Neurologic exam focus

›Neuro exam domains

›Lower extremity motor

›Hip flexion L2 to L3

›Knee extension L3 to L4

›Ankle dorsiflexion L4 to L5

›Great toe extension L5

›Ankle plantarflexion S1

›Sensory mapping

›Dermatomes L2 to S2

›Saddle region S2 to S5

›Reflexes

›Patellar reflex L3 to L4

›Achilles reflex S1

›Gait and functional testing

›Heel walk L4 to L5

›Toe walk S1

Sacral nerve function

›Sacral assessment

›Perianal sensation

›Light touch S2 to S5

›Pinprick S2 to S5

›Anal sphincter function

›Resting tone

›Voluntary squeeze

›Reflexes when feasible

›Anal wink

›Bulbocavernosus reflex

04Differential Diagnosis/ddx29

Life threatening and time sensitive causes

›High risk spinal canal syndromes

›Conus medullaris syndrome

›Early bladder dysfunction

›Symmetric leg weakness with mixed upper and lower motor findings

›Spinal epidural abscess

›Back pain with fever

›Elevated inflammatory markers

›Spinal epidural hematoma

›Acute severe back pain

›Anticoagulant exposure

›Malignant spinal canal compression

›Known malignancy

›Night pain and weight loss

Mimics and alternative explanations

›Cauda equina mimics

›Severe lumbar spinal stenosis without acute cauda equina syndrome

›Neurogenic claudication pattern

›Chronic symptom predominance

›Acute lumbar radiculopathy without sacral involvement

›Unilateral dermatomal symptoms

›Normal saddle sensation

›Peripheral neuropathy and autonomic dysfunction

›Diabetes related bladder dysfunction

›Chronic distal sensory loss

›Urinary retention non neurologic

›Benign prostatic hyperplasia

›Anticholinergic medication effect

05Laboratory Tests/lt27

Baseline and perioperative labs

›Baseline evaluation labs

›Basic metabolic panel indications

›Electrolytes for perioperative planning

›Creatinine for contrast planning if contrast imaging needed

›Complete blood count indications

›Leukocytosis for infection support

›Anemia for bleeding risk and operative planning

›Coagulation profile indications

›INR for warfarin exposure

›aPTT for heparin exposure

Infection and malignancy evaluation

›Etiology directed labs

›Inflammatory markers indications

›C reactive protein for epidural abscess risk stratification

›Erythrocyte sedimentation rate for epidural abscess risk stratification

›Blood cultures indications

›Fever or sepsis concern

›High suspicion epidural abscess before antibiotics when feasible

›Urinalysis indications

›Alternative urinary source of symptoms

›Baseline before catheter associated infection risk

Special situation testing

›Context specific tests

›Pregnancy testing

›Beta hCG for imaging planning in reproductive age patients

›Obstetric consultation trigger if pregnancy confirmed

›Type and screen

06Diagnostic Tests/dt45

Scoring Systems

›Clinical risk stratification tools

›Cauda equina red flag cluster

›Saddle anesthesia

›Urinary retention or overflow incontinence

›Bilateral leg symptoms

›Post void residual thresholds

›Post void residual greater than 200 mL supports urinary retention concern

›Very high post void residual supports high probability neurogenic retention

›Clinical phenotype labels

›Incomplete cauda equina syndrome with altered voiding sensation

›Cauda equina syndrome with retention

›Limitation statement

›No single symptom or exam finding reliably rules out cauda equina syndrome

MRI

›MRI lumbosacral spine

›Preferred modality

›Best soft tissue definition for disc, tumor, abscess, hematoma

›No ionizing radiation

›Technique considerations

›Sagittal and axial sequences through suspected level

›Contrast use when infection, tumor, or postoperative complication suspected

›Interpretation priorities

›Thecal sac compression degree

›Nerve root crowding

›Epidural collection characteristics

›Evidence label

›Class I recommendation based on expert consensus for urgent MRI when cauda equina syndrome suspected

07Disposition/dispo20

Level of care and transfer

›Disposition pathways

›Emergent admission triggers

›Suspected cauda equina syndrome pending imaging

›Confirmed compressive lesion on MRI or CT myelography

›Immediate transfer triggers

›No MRI capability with high clinical suspicion

›No spine surgery capability with confirmed compression

›Higher acuity monitoring triggers

›Sepsis concern with epidural abscess

›Rapidly progressive neurologic deficit

Discharge only when ruled out

›Safe discharge criteria

›Low suspicion after evaluation

›Normal saddle sensation

›Normal lower extremity strength and reflexes

›Bladder function reassurance

›Normal post void residual

›No new urinary retention symptoms

›Follow up plan

›Rapid outpatient spine or neurology follow up if persistent radicular symptoms

›Return precautions for any new bladder or saddle symptoms

08Treatment/t74

Surgical decompression and consultation

›Definitive management

›Surgical decompression strategy

›Laminectomy and discectomy for disc herniation compression

›Earlier decompression associated with improved bladder outcomes

›Class I recommendation based on expert consensus for urgent decompression once confirmed

›Drainage and decompression for epidural abscess

›Combined surgery and antibiotics for neurologic deficit or spinal instability

›Infectious diseases consultation for antimicrobial plan

›Decompression for epidural hematoma

›Immediate reversal of anticoagulation when relevant

›Neurosurgery urgent decompression pathway

Bladder management

›Urinary retention management

›Catheter strategy

›Urethral catheter for acute retention

›Strict intake and output

›Trial of void after definitive management and neurologic improvement

›Intermittent catheterization plan

›Consider after acute phase for neurogenic bladder

›Urology follow up for retention management

›Constipation management support

›Stool softener regimen to reduce straining

›Avoid bowel regimens that delay emergent imaging or surgery

Analgesia and symptom control

›Pain control regimen

›Acetaminophen

›1000 mg PO or IV every 6 hours

›Maximum 4000 mg per 24 hours

›Maximum 3000 mg per 24 hours in chronic alcohol use or frailty

›NSAID option if no contraindication

›Ibuprofen 400 mg PO every 6 hours

›Maximum 2400 mg per 24 hours for short course use

›Avoid in significant renal impairment or active GI bleeding

›Opioid for severe pain with monitoring

›Morphine 0.05 mg per kg IV

›Repeat every 10 minutes as needed for pain control

›Respiratory rate and sedation monitoring after each dose

›Hydromorphone 0.5 mg IV

›Repeat every 10 to 15 minutes as needed

›Reduced dose in opioid naive older adults

Steroids and etiology directed therapy

›Etiology specific medical therapy

›Suspected malignant spinal canal compression

›Dexamethasone regimen when cancer compression likely

›Dexamethasone 10 mg IV once

›Then dexamethasone 4 mg IV or PO every 6 hours

›Taper plan after oncology and spine input

›Class IIa recommendation based on expert consensus for neurologic symptom relief

›Suspected spinal epidural abscess

›Empiric antibiotics after cultures when feasible

›Vancomycin 15 to 20 mg per kg IV every 8 to 12 hours

›Trough guided dosing per local protocol

›Renal adjustment for reduced creatinine clearance

›Ceftriaxone 2 g IV every 24 hours

›Alternative cefepime 2 g IV every 8 hours for health care associated risk

›Metronidazole 500 mg IV every 8 hours if anaerobic concern

›Class I recommendation based on expert consensus for early antibiotics with neurologic deficit or sepsis

›Suspected spinal epidural hematoma with anticoagulant exposure

›Warfarin reversal

›Four factor PCC 50 units per kg IV

›Maximum 5000 units

›Repeat INR after administration

›Vitamin K 10 mg IV

›Slow infusion to reduce reaction risk

›Repeat INR monitoring

›Unfractionated heparin reversal

›Protamine 1 mg per 100 units heparin given in prior 2 to 3 hours

›Maximum 50 mg

›Hypotension and anaphylaxis monitoring

›Dabigatran reversal

›Idarucizumab 5 g IV

›Two consecutive 2.5 g doses

›Rebound anticoagulation monitoring

›Factor Xa inhibitor reversal when available

›Andexanet alfa per institutional protocol

›High cost and thrombotic risk consideration

›Hematology consultation for reversal guidance

09Special Populations/sp30

Pregnancy

›Pregnancy considerations

›Imaging strategy

›MRI preferred when available

›Avoid ionizing radiation when possible

›Contrast considerations

›Gadolinium avoidance unless essential for tumor or abscess definition

›Obstetric consultation for contrast risk discussion

›Medication safety

›Avoid NSAIDs in later pregnancy

›Opioid use with maternal and fetal monitoring as clinically indicated

Geriatric

›Older adult considerations

›Baseline urinary dysfunction confounding

›Benign prostatic hyperplasia overlap with retention symptoms

›Medication induced retention review

›Higher anticoagulant exposure risk

›Warfarin and DOAC use frequency

›Lower threshold for hematoma consideration

›Analgesia dosing adjustments

›Lower initial opioid dosing

›Delirium risk with sedating medications

Pediatrics

›Pediatric considerations

›Etiology differences

›Tumor and congenital lesions proportionally higher than adults

›Trauma and infection considerations

›Exam challenges

10Background/b35

Epidemiology

›Epidemiology summary

›Frequency and burden

›Rare emergency among back pain presentations

›Most commonly related to lumbar disc herniation in adults

›Risk distribution

›Increased risk with large central disc herniation

›Increased risk with cancer, infection, and anticoagulation exposure

›Outcome impact

›Delayed diagnosis associated with persistent bladder dysfunction

›Medicolegal high risk condition due to missed diagnosis harm

Pathophysiology

›Mechanism of injury

›Nerve root compression

›Compression of lumbosacral nerve roots within the thecal sac

›Ischemia and inflammation contribute to neurologic deficits

›Sacral root vulnerability

›S2 to S4 involvement drives bladder, bowel, and sexual dysfunction

›Sensory loss in saddle region reflects sacral root dysfunction

›Common compressive sources

›Disc material extrusion

›Epidural pus or phlegmon

›Epidural blood

›Tumor mass effect

Therapeutic Considerations

›Treatment rationale and evidence framing

›Time dependence

›Earlier decompression improves chance of bladder recovery

11Patient Discharge Instructions/pdi19

copy discharge instructions

›Discharge instructions

›Diagnosis status

›Cauda equina syndrome not found today

›Back pain or sciatica treatment plan provided

›Return to emergency department now for any of the following

›New trouble starting urination

›New inability to fully empty bladder

›New urine leakage or loss of bladder control

›New stool leakage or loss of bowel control

›New numbness in groin, genitals, or inner thighs

›New weakness in one or both legs

›New trouble walking

›Fever with worsening back pain

›Follow up plan

›Primary care follow up within 48 to 72 hours if symptoms persist

›Spine clinic or neurology follow up if ongoing radicular pain or sensory changes

›Medication safety

›Avoid driving if taking opioid pain medication

›Avoid alcohol with sedating medications

12References/r13

Clinical guidelines and key sources

›Reference set

›Spine surgery and neurosurgery consensus statements on cauda equina syndrome evaluation and urgent decompression

›Expert consensus supports urgent MRI for suspected cauda equina syndrome

›Expert consensus supports early decompression after confirmation

›Infectious diseases guidance for spinal epidural abscess antimicrobial therapy

›Empiric coverage includes MRSA and gram negative pathogens pending cultures

›Source control required when neurologic deficit or instability present

›Anticoagulation reversal guidance for life threatening bleeding and neuraxial hematoma

›Four factor PCC and vitamin K for warfarin associated major bleeding

›Specific reversal agents for dabigatran and factor Xa inhibitors when available

›Internal clinical management system instructions

›Twelve section format compliance reference

›Checkbox nesting and container rule reference

Evidence & Review

Evidence & Review